lazard - LAZ
LAZ
Close Chg Chg %
57.11 0.57 1.00%
Closed Market
57.68
+0.57 (1.00%)
Volume: 796.99K
Last Updated:
Nov 22, 2024, 3:59 PM EDT
Company Overview: lazard - LAZ
LAZ Key Data
| Open $57.49 | Day Range 57.05 - 57.93 |
| 52 Week Range 27.18 - 61.14 | Market Cap $4.99B |
| Shares Outstanding 87.41M | Public Float 85.09M |
| Beta 1.36 | Rev. Per Employee N/A |
| P/E Ratio 22.72 | EPS $2.72 |
| Yield 350.14% | Dividend $0.50 |
| EX-DIVIDEND DATE Nov 8, 2024 | SHORT INTEREST N/A |
| AVERAGE VOLUME 921.78K |
LAZ Performance
| 1 Week | 4.91% | ||
| 1 Month | 12.87% | ||
| 3 Months | 15.68% | ||
| 1 Year | 109.29% | ||
| 5 Years | 53.54% |
LAZ Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
10
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 58.375 | |
| Number of Ratings | 10 | Current Quarters Estimate | 0.688 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 2.231 | |
| Last Quarter’s Earnings | 0.38 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.77 | Next Fiscal Year Estimate | 4.06 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 8 | 8 | 9 | 9 |
| Mean Estimate | 0.69 | 0.83 | 2.23 | 4.06 |
| High Estimates | 0.80 | 1.00 | 2.35 | 4.86 |
| Low Estimate | 0.59 | 0.63 | 2.14 | 3.68 |
| Coefficient of Variance | 9.85 | 13.84 | 3.00 | 8.46 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 6 | 6 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 2 | 2 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Lazard - LAZ
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Lazard - LAZ
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Aug 20, 2024 | Richard D. Parsons Director | 107,952 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Aug 20, 2024 | Jane L. Mendillo Director | 72,618 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Aug 20, 2024 | Andrew M. Alper Director | 90,620 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 19, 2024 | Kenneth Marc Jacobs Executive Chairman; Director | 1,729,722 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $45.23 per share | 78,235,326.06 |
| Jul 19, 2024 | Kenneth Marc Jacobs Executive Chairman; Director | 330,279 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $45.23 per share | 14,938,519.17 |
| Jun 13, 2024 | Daniel H. Schulman Director | 5,926 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 13, 2024 | Stephen R. Howe Director | 5,914 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 6, 2024 | Iris Knobloch Director | 34,158 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 6, 2024 | Ann-Kristin Achleitner Director | 19,267 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 6, 2024 | Michelle E. Jarrard Director | 39,387 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 5, 2024 | Kenneth Marc Jacobs Executive Chairman; Director | 485,567 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $40 per share | 19,422,680.00 |
| Jun 5, 2024 | Kenneth Marc Jacobs Executive Chairman; Director | 489,716 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $41.21 per share | 20,181,196.36 |
| Jun 5, 2024 | Kenneth Marc Jacobs Executive Chairman; Director | 490,857 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $40.2 per share | 19,732,451.40 |
| Jun 5, 2024 | Kenneth Marc Jacobs Executive Chairman; Director | 1,982,829 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $40 per share | 79,313,160.00 |
| May 22, 2024 | Peter R. Orszag Chief Executive Officer; Director | 145,576 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 22, 2024 | Alexandra Soto Chief Operating Officer | 150,041 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 22, 2024 | Michael Gathy Chief Accounting Officer | 5,205 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2024 | Peter R. Orszag Chief Executive Officer; Director | 138,340 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2024 | Peter R. Orszag Chief Executive Officer; Director | 101,522 | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $39.2 per share | 3,979,662.40 |
| Mar 14, 2024 | Evan Lawrence Russo CEO of Asset Management | 377,448 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Lazard in the News
Junior bankers at Lazard now the highest-paid on Wall Street, pulling in $200K
Junior bankers at boutique firm Lazard are now the highest paid on Wall Street, after Lazard raised salaries for all associates by $50,000, according to a report.